Evidence map›Paper›PMID 31684097›Full record

ArticleVaccines2019

Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage.

Stéphanie Fougerolle, Christine Fortier, Loïc Legrand, Marion Jourdan, Christel Marcillaud-Pitel, Stéphane Pronost, Romain Paillot

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stéphanie FougerolleFrank Duncombe, LABÉO, 14280 Saint Contest, France. st.fougerolle@gmail.com.
Christine FortierFrank Duncombe, LABÉO, 14280 Saint Contest, France. christine.fortier@laboratoire-labeo.fr.
Loïc LegrandFrank Duncombe, LABÉO, 14280 Saint Contest, France. loic.legrand@laboratoire-labeo.fr.
Marion JourdanRESPE, 3 rue Nelson Mandela, 14280 Saint-Contest, France. technicien@respe.net.
Christel Marcillaud-PitelRESPE, 3 rue Nelson Mandela, 14280 Saint-Contest, France. c.marcillaud-pitel@respe.net.
Stéphane PronostFrank Duncombe, LABÉO, 14280 Saint Contest, France. stephane.pronost@laboratoire-labeo.fr.
Romain PaillotFrank Duncombe, LABÉO, 14280 Saint Contest, France. romain.paillot@laboratoire-labeo.fr.
Labéo · FR

Funding

Fonds Eperon N12-2017IFCE 2017-008Région Normandie 17E01598/17P04324
6 · The paper itself

Abstract

Every year, several epizooties of equine influenza (EI) are reported worldwide. However, no EI case has been identified in France between 2015 and late 2018, despite an effective field surveillance of the pathogen and the disease. Vaccination against equine influenza virus (EIV) remains to this day one of the most effective methods to prevent or limit EI outbreaks and the lack of detection of the pathogen could be linked to vaccination coverage. The aim of this study was to evaluate EI immunity and vaccine coverage in France through a large-scale serological study. A total of 3004 archived surplus serums from French horses of all ages, breeds and sexes were selected from four different geographical regions and categories (i.e., sanitary check prior to exportation, sale, breeding protocol or illness diagnosis). EIV-specific antibody response was measured by single radial hemolysis (SRH) and an EIV-nucleoprotein (NP) ELISA (used as a DIVA test). Overall immunity coverage against EIV infection (i.e., titers induced by vaccination and/or natural infection above the clinical protection threshold) reached 87.6%. The EIV NP ELISA results showed that 83% of SRH positive serum samples from young horses (≤3 years old) did not have NP antibodies, which indicates that the SRH antibody response was likely induced by EI vaccination alone (the HA recombinant canarypoxvirus-based EI vaccine is mostly used in France) and supports the absence of EIV circulation in French horse populations between 2015 and late 2018, as reported by the French equine infectious diseases surveillance network (RESPE). Results from this study confirm a strong EI immunity in a large cohort of French horses, which provides an explanation to the lack of clinical EI in France in recent years and highlights the success of vaccination against this disease. However, such EI protection has been challenged since late 2018 by the incursion in the EU of a Florida Clade 1 sub-lineage EIV (undetected in France since 2009), which is also reported here.

Indexed as

DIVA testepizootyequine influenza virusFlorida Clade 1 (FC1)horseimmune coveragesurveillancevaccination

Identifiers

PMID31684097
PMCPMC6963532
OpenAlexW2988194238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.